Clinical Trials
42 trialsOncologic and Functional Outcome and Quality of Life in Patients Treated for Laryngeal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study of the Risk of Pharyngocutaneous Fistula in a Population of Patients Undergoing Total Laryngectomy and Creation of a Score for Pre-operative Risk Stratification.
Regina Elena Cancer Institute
PARVA
University of Virginia
Olaparib and Radiotherapy in Head and Neck Cancer
The Netherlands Cancer Institute
Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers
Regina Elena Cancer Institute
SPPDPL
Guangdong Provincial People's Hospital
PRO-IMMUNO
University Medical Center Groningen
iCHRTL
Maria Sklodowska-Curie National Research Institute of Oncology
Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer
George Washington University
Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer
Clinical Centre of Serbia
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer
Shanghai Yunying Medical Technology
Vitamin-D Receptor in Laryngeal Squamous Cell Carcinoma
Sohag University
VC-Larynx
National Cancer Institute, Egypt
Benefit of Enhanced Contact Endoscopy in Pre-histological Diagnosis of Laryngeal and Hypopharyngeal Mucosal Lesions
University Hospital Ostrava
Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma
Fudan University
INSIGHT
Fudan University
Cell-free Tumor DNA in Head and Neck Cancer Patients
Rigshospitalet, Denmark
PIONEER
SpeciCare
ILAL
Tianjin First Central Hospital
Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients
Second Affiliated Hospital, School of Medicine, Zhejiang University
Testing Accountability in Patient Adherence
M.D. Anderson Cancer Center
Nomograms to Precisely Predict Conditional Risk of Survival for Patients With Laryngeal Cancer
First Affiliated Hospital, Sun Yat-Sen University
Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use
M.D. Anderson Cancer Center
Nomograms to Precisely Predict Conditional Risk of Recurrence for Patients With Laryngeal Cancer
First Affiliated Hospital, Sun Yat-Sen University
A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
TEP
HealthCare Global Enterprise Ltd.
KTP vs CO2 Laser for the Treatment of Laryngeal Carcinoma
Kaplan Medical Center
Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck
National Cancer Institute (NCI)
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
National Cancer Institute (NCI)
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
National Cancer Institute (NCI)
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
National Cancer Institute (NCI)
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
the Comparison of Voice Quality in Early Laryngeal Cancer Between Surgery and Radiotherapy
Tehran University of Medical Sciences
Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy
University Hospital, Strasbourg, France
Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of Life
Tel-Aviv Sourasky Medical Center
Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.
All India Institute of Medical Sciences
Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma
Southern Medical University, China
Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer
Rabin Medical Center
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
National Cancer Institute (NCI)
The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
National Taiwan University Hospital
The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis
National Taiwan University Hospital
The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
National Taiwan University Hospital